Crossmark

Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy

Crossref DOI link: https://doi.org/10.1186/s13039-017-0317-5

Published Online: 2017-05-04

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Urbschat, Steffi

Sippl, Christoph

Engelhardt, Jana

Kammers, Kai

Oertel, Joachim

Ketter, Ralf https://orcid.org/0000-0001-7790-3425
Funding

Funding for this research was provided by:

Archimedes Pharma (L204150209)

Kyowa Kirin GmbH